4th March 2021
EIT Health and HealthTech for Care have renewed their partnership for the organisation of HealthTech Innovation Days, reinforcing its European positioning through collaborations with BioDeutschland and BioWIN.
Following the success of the second edition of the HealthTech Innovation Days in October 2020, supported by high-level French and European institutions, the third edition aims to establish itself as the reference event for global players in the European health ecosystem and will be held on 4 and 5 October 2021.
By joining forces around HealthTech For Care they prove their common commitment to supporting and promoting access to healthcare for all and to new medical technologies and new medicines.
“With more than 250 members, EIT Health is the largest European consortium in the health sector and brings together all types of life science players from more than 20 countries. From the start, HealthTech For Care has had the ambition to make HTID an event in Paris which promotes access to all patients in life sciences technologies. The renewal of the partnership with EIT Health and the new collaborations with BIO Deutschland and BioWin are perfectly in line with our strategy. I am delighted with this European collaboration.” said Maryvonne Hiance, President of HealthTech For Care.
With the support of the European Commission and the European Investment Fund (EIF), EIT Health has chosen to partner with HealthTech For Care to host its co-investment programme Venture Centre of Excellence (VCoE) members, and organise VCoE member-exclusive sessions at HealthTech Innovation Days, establishing the event as a key milestone for health investment.
The Venture Centre of Excellence (VCoE) is a pan-European open innovation programme, created by EIT Health and the EIF, benefiting from a €150m financial support from the European Commission, as announced during HTID 2020. The programme is expected to catalyse up to 2 billion Euro of investment in life sciences over the next 15 years. The VCoE will strengthen the collaboration and investment capacities of its members, thereby supporting cutting-edge technologies, commercialisation and the scale-up of products and services in the European ecosystem.
“We look forward to the renewal of this partnership as well as the collaboration with other key players who contribute to making HealthTech Innovation Days a leading event in Europe for health innovation stakeholders. Our commitment to this collaboration is made clear by the VCoE’s decision to hold an exclusive member event during HealthTech Innovation Days 2021, we thereby hope to facilitate and strengthen relationships between corporates and academics selected by EIT Health which have subscribed to the programme, and the venture capital companies selected by the European Investment Fund” said Jean-Marc Bourez Managing Director of EIT Health France and Head of the Venture Centre of Excellence.
In order to strengthen HealthTech For Care’s role as a European General Interest Endowment Fund, HealthTech For Care has signed two new collaborations: BIO Deutschland, the German Biotechnology Association that currently has over 340 members and BioWIN, the health competitiveness cluster in Wallonia with 249 members. These collaborations show a common willingness on the part of several European clusters to collaborate together and accelerate innovation in health and make care more quickly accessible to patients.
EIT Health rewards societal impact at Pitch Contest
Amparo takes 1st place at MedtecLIVE
EIT Health supported Optellum in AI world-first
Breakthrough in lung cancer detection technology
EIT Health-entrepreneur on Medicine’s Maker ‘Power List’
Evelina Vågesjö, CEO at Ilya Pharma